ARKAITZ
CARRACEDO PEREZ
INVESTIGADOR/A DISTINGUIDO/A
Barcelona Institute of Science and Technology
Barcelona, EspañaPublications en collaboration avec des chercheurs de Barcelona Institute of Science and Technology (1)
2020
-
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo
Journal of Clinical Investigation, Vol. 130, Núm. 5, pp. 2435-2450